Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Ordinary Shares, nominal value Euro 0.04 per share
-
Shares outstanding
-
105,371,575
-
Total 13F shares
-
29,107,854
-
Share change
-
-176,496
-
Total reported value
-
$176,974,000
-
Put/Call ratio
-
12%
-
Price per share
-
$6.08
-
Number of holders
-
43
-
Value change
-
-$802,484
-
Number of buys
-
22
-
Number of sells
-
18
Institutional Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) as of Q2 2020
As of 30 Jun 2020,
ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,107,854 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, WELLINGTON MANAGEMENT GROUP LLP, ADAGE CAPITAL PARTNERS GP, L.L.C., GOLDMAN SACHS GROUP INC, JENNISON ASSOCIATES LLC, Aquilo Capital Management, LLC, Artal Group S.A., DAFNA Capital Management LLC, BlackRock Inc., and UBS Group AG.
This page lists
43
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.